2025-04-04 19:35:50
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Astec LifeSciences Ltd Q3 FY24 consolidated loss at Rs. 24.33 crores
Posted On : 2024-01-25 17:37:50( TIMEZONE : IST )
Astec LifeSciences Limited has reported Consolidated financial results for the period ended December 31, 2023.
Financial Results (Q3 FY2024) - QoQ Comparison
The company has reported total income of Rs. 51.7038 crores during the period ended December 31, 2023 as compared to Rs. 111.7681 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs. -24.3342 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. -13.4270 crores for the period ended September 30, 2023.
The company has reported EPS of Rs. -12.41 for the period ended December 31, 2023 as compared to Rs. -6.85 for the period ended September 30, 2023.
| Financials | Q3 FY2024 | Q2 FY2024 | % Change |
| Total Income | ₹ 51.7038 crs | ₹111.7681 crs |  -53.74% |
| Net Profit | ₹-24.3342 crs | ₹-13.4270 crs |  81.23% |
| EPS | ₹-12.41 | ₹-6.85 | 81.17% |
Financial Results (Q3 FY2024) - YoY Comparison
The company has reported total income of Rs. 51.7038 crores during the period ended December 31, 2023 as compared to Rs.120.9697 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.-24.3342 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.0.8397 crores for the period ended December 31, 2022.
The company has reported EPS of Rs.-12.41 for the period ended December 31, 2023 as compared to Rs.0.43 for the period ended December 31, 2022.
| Financials | Q3 FY2024 | Q3 FY2023 | % Change |
| Total Income | ₹ 51.7038 crs | ₹120.9697 crs | -57.26% |
| Net Profit | ₹-24.3342 crs | ₹0.8397 crs | -2,997.96% |
| EPS | ₹-12.41 | ₹0.43 | -2,986.05% |
Financial Results (9 Months Ended FY2024) - YoY Comparison
The company has reported total income of Rs.308.0290 crores during the 9 Months period ended December 31, 2023 as compared to Rs.511.6793 crores during the 9 Months period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.-45.9557 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.30.5478 crores for the 9 Months period ended December 31, 2022.
The company has reported EPS of Rs.-23.44 for the 9 Months period ended December 31, 2023 as compared to Rs.15.58 for the 9 Months period ended December 31, 2022.
| Financials | 9 Months Ended FY2024 | 9 Months Ended FY2023 | % Change |
| Total Income | ₹308.0290 crs | ₹511.6793 crs | -39.80% |
| Net Profit | ₹-45.9557 crs | ₹30.5478 crs | -250.44% |
| EPS | ₹-23.44 | ₹15.58 | -250.45% |
Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 997.80 as compared to the previous close of Rs. 977.30. The total number of shares traded during the day was 2573 in over 258 trades.
The stock hit an intraday high of Rs. 1029.00 and intraday low of 985.50. The net turnover during the day was Rs. 2602815.00.
